Viral hepatitis in 2021: The challenges remaining and how we should tackle them

doi:10.3748/wjg.v28.i1.76

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6535)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

648

WORD

125

HTML

4434

Figures (1-2)

332

Tables (1-2)

251

Sum=5790

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

332

Download

413

Sum=745

Jan 7, 2022 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jan 7, 2022; 28(1): 76-95
Published online Jan 7, 2022. doi: 10.3748/wjg.v28.i1.76

Table 1 Recommendations for hepatocellular carcinoma surveillance in patients with hepatitis C virus achieving sustained virologic response

Guideline	Recommendation
EASL[114] 2020	Survey patients with advanced fibrosis (F3) or cirrhosis (F4)
AASLD[115]	Survey cirrhotic patients
Asia-Pacific[116]	Survey cirrhotic patients; Survey patients with any histologic stage of HCV with comorbidities, such as alcohol abuse and diabetes mellitus

HCV: Hepatitis C virus. AASLD: American Association for the Study of Liver Diseases; EASL: European Association for the Study of the Liver.

Citation: Dunn R, Wetten A, McPherson S, Donnelly MC. Viral hepatitis in 2021: The challenges remaining and how we should tackle them. World J Gastroenterol 2022; 28(1): 76-95
URL: https://www.wjgnet.com/1007-9327/full/v28/i1/76.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i1.76